Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)

<p>Abstract</p> <p>Background</p> <p>Severe hypoglycaemia (SH) is one of the most feared complications of type 1 diabetes (T1DM) with a reported prevalence of nearly 40%. In randomized trials of Multiple Daily Injections (MDI) and Continuous Subcutaneous Insulin Infusio...

Full description

Bibliographic Details
Main Authors: Little Stuart, Chadwick Thomas, Choudhary Pratik, Brennand Cath, Stickland Julia, Barendse Shalleen, Olateju Tolulope, Leelarathna Lalantha, Walkinshaw Emma, Tan Horng K, Marshall Sally M, Thomas Reena M, Heller Simon, Evans Mark, Kerr David, Flanagan Daniel, Speight Jane, Shaw James AM
Format: Article
Language:English
Published: BMC 2012-12-01
Series:BMC Endocrine Disorders
Online Access:http://www.biomedcentral.com/1472-6823/12/33